BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33609792)

  • 1. Rheumatoid arthritis: Extra-articular manifestations and comorbidities.
    Figus FA; Piga M; Azzolin I; McConnell R; Iagnocco A
    Autoimmun Rev; 2021 Apr; 20(4):102776. PubMed ID: 33609792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis Prevention.
    Giles JT
    Clin Ther; 2019 Jul; 41(7):1246-1255. PubMed ID: 31196641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-articular manifestations and complications of rheumatoid arthritis.
    Young A; Koduri G
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):907-27. PubMed ID: 17870035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
    Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
    Fragoulis GE; Panayotidis I; Nikiphorou E
    Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-morbidity in patients with early rheumatoid arthritis - inflammation matters.
    Innala L; Sjöberg C; Möller B; Ljung L; Smedby T; Södergren A; Magnusson S; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    Arthritis Res Ther; 2016 Jan; 18():33. PubMed ID: 26818851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-articular rheumatoid arthritis.
    Turesson C
    Curr Opin Rheumatol; 2013 May; 25(3):360-6. PubMed ID: 23425964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical features of rheumatoid arthritis.
    Grassi W; De Angelis R; Lamanna G; Cervini C
    Eur J Radiol; 1998 May; 27 Suppl 1():S18-24. PubMed ID: 9652497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Manifestations in Rheumatoid Arthritis.
    Sanghavi N; Ingrassia JP; Korem S; Ash J; Pan S; Wasserman A
    Cardiol Rev; 2024 Mar-Apr 01; 32(2):146-152. PubMed ID: 36729119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular comorbidities in rheumatoid arthritis].
    Krüger K; Nüßlein H
    Z Rheumatol; 2019 Apr; 78(3):221-227. PubMed ID: 30656399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cardiovascular disease in rheumatoid arthritis.
    Gabriel SE; Crowson CS
    Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatoid arthritis: a cardiovascular disease?].
    Daïen CI; Fesler P
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and rheumatoid arthritis: an update.
    Charles-Schoeman C
    Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.
    Batko B; Urbański K; Świerkot J; Wiland P; Raciborski F; Jędrzejewski M; Koziej M; Cześnikiewicz-Guzik M; Guzik TJ; Stajszczyk M
    Clin Rheumatol; 2019 Sep; 38(9):2473-2481. PubMed ID: 31076943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
    Meissner Y; Zink A; Kekow J; Rockwitz K; Liebhaber A; Zinke S; Gerhold K; Richter A; Listing J; Strangfeld A
    Arthritis Res Ther; 2016 Aug; 18(1):183. PubMed ID: 27495156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-articular Manifestations in Rheumatoid Arthritis.
    Cojocaru M; Cojocaru IM; Silosi I; Vrabie CD; Tanasescu R
    Maedica (Bucur); 2010 Dec; 5(4):286-91. PubMed ID: 21977172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.
    Amezaga Urruela M; Suarez-Almazor ME
    Curr Rheumatol Rep; 2012 Oct; 14(5):428-37. PubMed ID: 22802154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe use of antirheumatic agents in patients with comorbidities.
    Makol A; Wright K; Matteson EL
    Rheum Dis Clin North Am; 2012 Nov; 38(4):771-93. PubMed ID: 23137582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cardiovascular disease in rheumatoid arthritis.
    Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
    Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.